The overuse of alkylating medications such as cyclophosphamide and busulfan resulted in a decrease in antioxidant agents such as SDF-1 and SOD-2 (105)
India is projected to show the highest regional CAGR at 8.4% during the forecast period, driven by the growing prevalence of diabetes, increasing healthcare access, and expanding awareness about GLP-1 therapies in the region
Improved glycemic control: These injections help manage blood sugar levels, benefiting those with type 2 diabetes
CRAs Becky Davis examines how these dramatic price reductions, combined with Direct-to-Patient distribution models, may be accelerating employer migration away from traditional health plans and creating new competitive opportunities for manufacturers willing to bypass traditional PBM barriers.
All articles Tirzepatide Side Effects: Causes & Management Reading time: 5 min Author Published on Updated on Weight loss Get expert guidance and a personalized care plan designed around you
In a controlled study, patients (121 years of age) with newly diagnosed ALL or lymphoblastic lymphoma were given pegaspargase (2500 IU/M2, once induction, 15 doses every 2 weeks starting at week 7) or calaspargase pegol (2500 IU/M2, once induction, 10 doses every 3 weeks starting at week 7)
